Selection of human hematopoetic stem cells using EPCR
US11725187B2 · kind B2 · utility
0Cited by
0References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 31, 2017 |
| Grant date | Aug 15, 2023 |
| Priority date | — |
| Expiry date | Jan 3, 2039 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/569
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
It is provided a method of expanding ex vivo hematopoietic stem cells (HSC), the method comprising selecting a population of Endothelial Protein C Receptor (EPCR)+ HSC, culturing the selected HSC thereby expanding said EPCR+ HSC and the use of the expanded EPCR+ HSC for stem cells transplantation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.